• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鉴定乳腺癌中与 CCND1 相关的 lncRNAs 的表达。

Identification of expression of CCND1-related lncRNAs in breast cancer.

机构信息

Department of Biology, College of Education, Salahaddin University-Erbil, Kurdistan Region, Iraq; Department of Pharmacognosy, College of Pharmacy, Hawler Medical University, Kurdistan Region, Iraq.

Department of Biology, College of Education, Salahaddin University-Erbil, Kurdistan Region, Iraq.

出版信息

Pathol Res Pract. 2022 Aug;236:154009. doi: 10.1016/j.prp.2022.154009. Epub 2022 Jul 1.

DOI:10.1016/j.prp.2022.154009
PMID:35803208
Abstract

Cyclin D1 has been shown to participate in the pathogenesis of breast cancer. This cell cycle-related protein has direct or indirect interactions with long non-coding RNAs (lncRNAs). In the present two-step study, we first identified CCND1-related lncRNAs through an in silico approach. Then, we measured expression of CCND1 mRNA and five lncRNAs in paired breast cancer samples and their matched non-cancerous samples obtained from adjacent tissues. HOTTIP expression was significantly higher in breast cancer tissues compared with adjacent tissues (expression ratio (95% CI)= 4.63 (1.56-13.76), P value= 0.0070). Similarly, CBR3-AS1 was up-regulated in cancerous tissues compared with control tissues (expression ration (95% CI)= 3.26 (1.35-7.86), P value= 0.0122). Expression of HOTTIP was higher in estrogen receptor (ER) negative samples compared with ER positive ones (-4.35 ± 1.33 versus -4.63 ± 0.62, P value=0.002). CBR3-AS1 could differentiate between these two sets of samples with AUC±SD, sensitivity, specificity and P values of 0.7 ± 0.05, 0.9, 0.49 and 0.003, respectively. These values were 0.68 ± 0.04, 0.87, 0.34 and 0.04 for HOTTIP. Although we could not find difference in expression of CCND1 between these two sets of samples, we reported up-regulation of two CCND1-related lncRNAs in breast cancer samples. These lncRNAs are putative markers for breast cancer.

摘要

Cyclin D1 已被证明参与乳腺癌的发病机制。这种细胞周期相关蛋白与长链非编码 RNA(lncRNA)直接或间接相互作用。在本研究的两步法中,我们首先通过计算方法鉴定了与 CCND1 相关的 lncRNA。然后,我们测量了配对的乳腺癌样本及其来自相邻组织的匹配非癌样本中 CCND1 mRNA 和五种 lncRNA 的表达。HOTTIP 在乳腺癌组织中的表达明显高于相邻组织(表达比(95%CI)=4.63(1.56-13.76),P 值=0.0070)。同样,CBR3-AS1 在癌组织中的表达高于对照组织(表达比(95%CI)=3.26(1.35-7.86),P 值=0.0122)。在雌激素受体(ER)阴性样本中,HOTTIP 的表达高于 ER 阳性样本(-4.35±1.33 与-4.63±0.62,P 值=0.002)。CBR3-AS1 可以用 AUC±SD、灵敏度、特异性和 P 值来区分这两组样本,分别为 0.7±0.05、0.9、0.49 和 0.003。HOTTIP 的这些值分别为 0.68±0.04、0.87、0.34 和 0.04。虽然我们没有发现这两组样本中 CCND1 的表达存在差异,但我们报道了在乳腺癌样本中两个 CCND1 相关 lncRNA 的上调。这些 lncRNA 是乳腺癌的潜在标志物。

相似文献

1
Identification of expression of CCND1-related lncRNAs in breast cancer.鉴定乳腺癌中与 CCND1 相关的 lncRNAs 的表达。
Pathol Res Pract. 2022 Aug;236:154009. doi: 10.1016/j.prp.2022.154009. Epub 2022 Jul 1.
2
Expression analysis of autophagy-related long non-coding RNAs in Iranian patients with breast cancer.伊朗乳腺癌患者自噬相关长非编码 RNA 的表达分析。
Pathol Res Pract. 2022 Nov;239:154146. doi: 10.1016/j.prp.2022.154146. Epub 2022 Sep 29.
3
Expression analysis of NF-κB interacting long noncoding RNAs in breast cancer.NF-κB 相互作用的长非编码 RNA 在乳腺癌中的表达分析。
Exp Mol Pathol. 2020 Feb;112:104359. doi: 10.1016/j.yexmp.2019.104359. Epub 2019 Dec 14.
4
Expression analysis of Rho GTPase-related lncRNAs in breast cancer.Rho GTP酶相关长链非编码RNA在乳腺癌中的表达分析
Pathol Res Pract. 2023 Apr;244:154429. doi: 10.1016/j.prp.2023.154429. Epub 2023 Mar 27.
5
Long Non-Coding RNAs Expression in Breast Cancer: CBR3-AS1 LncRNA as a Sensitive Biomarker.长链非编码 RNA 在乳腺癌中的表达:CBR3-AS1 lncRNA 作为一种敏感的生物标志物。
Asian Pac J Cancer Prev. 2021 Sep 1;22(9):2897-2902. doi: 10.31557/APJCP.2021.22.9.2897.
6
Genome-wide study of ER-regulated lncRNAs shows AP000439.3 may function as a key regulator of cell cycle in breast cancer.全基因组范围内研究 ER 调节的长非编码 RNA 显示,AP000439.3 可能在乳腺癌中作为细胞周期的关键调节因子发挥作用。
Oncol Rep. 2017 Nov;38(5):3227-3237. doi: 10.3892/or.2017.5975. Epub 2017 Sep 20.
7
LINC00473 mediates cyclin D1 expression through a balance between activation and repression signals in breast cancer cells.LINC00473 通过在乳腺癌细胞中激活和抑制信号之间的平衡来调节细胞周期蛋白 D1 的表达。
FEBS Lett. 2019 Apr;593(7):751-759. doi: 10.1002/1873-3468.13353. Epub 2019 Mar 18.
8
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.细胞周期蛋白D1的高表达与雌激素受体(ER)阳性乳腺癌女性的高增殖率及死亡风险增加相关,但在ER阴性乳腺癌中并非如此。
Breast Cancer Res Treat. 2017 Aug;164(3):667-678. doi: 10.1007/s10549-017-4294-5. Epub 2017 May 20.
9
Down-regulation of a panel of immune-related lncRNAs in breast cancer.乳腺癌中一组免疫相关 lncRNA 的下调。
Pathol Res Pract. 2021 Aug;224:153534. doi: 10.1016/j.prp.2021.153534. Epub 2021 Jun 22.
10
Long non-coding RNA NR2F1-AS1 promoted proliferation and migration yet suppressed apoptosis of thyroid cancer cells through regulating miRNA-338-3p/CCND1 axis.长链非编码 RNA NR2F1-AS1 通过调控 miRNA-338-3p/CCND1 轴促进甲状腺癌细胞的增殖、迁移,抑制其凋亡。
J Cell Mol Med. 2019 Sep;23(9):5907-5919. doi: 10.1111/jcmm.14386. Epub 2019 Jul 14.

引用本文的文献

1
The long antisense non-coding RNA HOXA transcript at the distal tip (LncRNA HOTTIP) in health and disease: a comprehensive review and in silico analysis.健康与疾病中的远端长反义非编码RNA HOXA转录本(LncRNA HOTTIP):综述与计算机分析
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 5. doi: 10.1007/s00210-025-04372-9.
2
Genomic Landscape of Breast Cancer: Study Across Diverse Ethnic Groups.乳腺癌的基因组格局:不同种族群体的研究
Diseases. 2025 Mar 17;13(3):86. doi: 10.3390/diseases13030086.
3
Genetic variation perspective reveals potential drug targets for subtypes of endometrial cancer.
从遗传变异角度揭示子宫内膜癌亚型的潜在药物靶点。
Sci Rep. 2024 Nov 15;14(1):28180. doi: 10.1038/s41598-024-78689-5.
4
Anoikis resistance regulates immune infiltration and drug sensitivity in clear-cell renal cell carcinoma: insights from multi omics, single cell analysis and experiment.失巢凋亡抵抗调节透明细胞肾细胞癌中的免疫浸润和药物敏感性:多组学、单细胞分析和实验的见解。
Front Immunol. 2024 Jun 17;15:1427475. doi: 10.3389/fimmu.2024.1427475. eCollection 2024.
5
Interaction between SIRT1 and non-coding RNAs in different disorders.SIRT1与非编码RNA在不同疾病中的相互作用。
Front Genet. 2023 Jun 27;14:1121982. doi: 10.3389/fgene.2023.1121982. eCollection 2023.
6
A review on the role of HAND2-AS1 in cancer.HAND2-AS1 在癌症中的作用研究综述。
Clin Exp Med. 2023 Nov;23(7):3179-3188. doi: 10.1007/s10238-023-01092-3. Epub 2023 May 19.
7
Role of miR-424 in the carcinogenesis.miR-424 在癌症发生中的作用。
Clin Transl Oncol. 2024 Jan;26(1):16-38. doi: 10.1007/s12094-023-03209-2. Epub 2023 May 13.
8
Coding roles of long non-coding RNAs in breast cancer: Emerging molecular diagnostic biomarkers and potential therapeutic targets with special reference to chemotherapy resistance.长链非编码RNA在乳腺癌中的编码作用:新兴的分子诊断生物标志物及潜在治疗靶点,特别涉及化疗耐药性
Front Genet. 2023 Jan 6;13:993687. doi: 10.3389/fgene.2022.993687. eCollection 2022.
9
Functional interplay between long non-coding RNAs and Breast CSCs.长链非编码RNA与乳腺肿瘤干细胞之间的功能相互作用
Cancer Cell Int. 2022 Jul 21;22(1):233. doi: 10.1186/s12935-022-02653-4.